Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 293 of 6351
-
Can a blood patch or talc seal a collapsed lung faster?
Disease control Not yet recruitingBackground: A pilot study to assess the feasibility of a randomisation trial protocol comparing intrapleural talc pleurodesis versus autologous blood patch therapy (ABPT) in patients with secondary spontaneous pneumothorax (SSP) complicated by persistent air leak (PAL). The propo…
Phase 2/3 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
A new exercise for the eyes: could it restore 3D vision?
Disease control Not yet recruitingThis study evaluates a novel attention-based binocular visual search training paradigm designed to improve stereopsis (stereo vision) in individuals with impaired binocular vision. Disruptions in balanced binocular input, such as from strabismus or anisometropia, often lead to de…
Sponsor: Centre for Eye and Vision Research • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
A steroid premedication may tame the immune reaction to a melanoma therapy
Prevention Not yet recruitingThe goal of this clinical trial is to learn if a low dose of dexamethasone can prevent cytokine release syndrome in participants treated with tebentafusp for advanced uveal melanoma. The main questions the study aims to answer are: How many participants get cytokine release synd…
Phase 2 • Sponsor: University of California, San Diego • Aim: Prevention
Last updated Sep 05, 2026 00:00 UTC
-
New radiation trick may spare rectal cancer patients from surgery
Disease control Recruiting nowRectal cancer patients who do not achieve a complete response to standard of care chemotherapy and radiation often require surgical resection as part of curative intent therapy. This study will evaluate whether additional "focal" radiation delivered internally (rectal brachythera…
Phase 2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Weight-loss shot plus IUD may help reverse womb cancer without surgery
Disease control Not yet recruitingThis phase II trial studies whether adding tirzepatide injections to a levonorgestrel intrauterine device (LNG-IUD) improves pathologic response (absence of cancer cells in tissue samples after treatment) in women with endometrial atypical hyperplasia/endometrial intraepithelial …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New pill aims to cut lung infections in bronchiectasis patients
Disease control Not yet recruitingThis study aims to find out whether the tablet CHF10196 is safe and effective for people with non-cystic fibrosis bronchiectasis, a long-term lung disease that causes widened airways, mucus buildup, infections, and flare ups of symptoms. The main goal is to see whether CHF10196 c…
Phase 3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could zapping kidney nerves tame stubborn high blood pressure and save hearts?
Disease control Not yet recruitingEMBRACE is a randomized, controlled, multicenter clinical study evaluating the effect of renal denervation on clinical adverse events in hypertensive patients undergoing staged percutaneous coronary intervention (PCI) for multivessel coronary artery disease.
Sponsor: Ceric Sàrl • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New hope for AML patients: experimental drug IPN60340 enters key trial
Disease control Not yet recruitingThe purpose of this study is to find out how well the study drug IPN60340 works to treat participants with acute myeloid leukemia. Acute myeloid leukemia is a rare blood cancer that grows quickly. This study's main aim is to compare the percentage of participants who reach comple…
Phase 2/3 • Sponsor: Ipsen • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New chemo combo shows promise for tough lung cancer
Disease control Not yet recruitingThis clinical trial is designed to compare and evaluate the efficacy and safety of the combination therapy of Lurbinectedin plus Paclitaxel (Combination Arm) versus Paclitaxel monotherapy (Monotherapy Arm) in patients with extensive-stage small-cell lung cancer whose disease has …
Phase 2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
HIV-Positive livers for HIV-Positive patients: a new hope?
Disease control Recruiting nowThis research is being done to better understand opportunistic infections and cancer in transplant recipients with HIV who receive livers from a donor with HIV compared to livers from donors without HIV.
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Sep 10, 2026 01:00 UTC
-
Could a daily pill ease leg pain and swelling from vein disease?
Disease control Not yet recruitingThis multicenter, randomized, double-blind study is a phase III evaluates the safety and effectiveness of CLR prolonged-release tablets in patients with chronic venous insufficiency, has been shown to be effective in reducing the symptoms of itching, edema, spontaneous pain, and …
Phase 3 • Sponsor: Barbara Maglione • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can a talk therapy that boosts Self-Understanding prevent suicide?
Disease control Not yet recruitingThis study aims to validate MBT as an effective and viable intervention for implementation in public health services, with the potential to directly impact suicide prevention policies in the region.
Sponsor: Fundación Judío Panameña (JUPA) • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
A smartphone camera may help emergency doctors spot severe breathing trouble — a trial puts it to the test
Disease control Not yet recruitingDyspnea is the subjective sensation of difficult or uncomfortable breathing. It accounts for approximately 10% of emergency department visits and 8% of calls to Emergency Medical Communication Centers. Nearly half of patients presenting with dyspnea require hospital admission, 15…
Sponsor: Poitiers University Hospital • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a tiny implant fix complex heart valve leaks without open surgery?
Disease control Not yet recruitingA pilot study to evaluate the safety and performance of the MRace System to treat severe mitral regurgitation and to gather data on its performance thereby providing guidance for future clinical development. The study is a single-arm registry with the last follow-up visit at 5 ye…
Sponsor: Polares Medical SA • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can 3D-Printed models unlock personalized blood cancer therapies?
Knowledge-focused Not yet recruitingAdult patients with chronic lymphocytic leukemia (CLL), splenic marginal-zone lymphoma (SMZL) and hairy cell leukemia (HCL) followed at participating clinical sites will be enrolled and undergo sampling of additional amount of blood during the blood draws performed as part of sta…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
One injection vs. two: a new approach to shoulder surgery pain?
Symptom relief Not yet recruitingThis prospective, randomized, patient- and assessor-blinded, single-center non-inferiority trial will compare the analgesic efficacy of the Shoulder Posterior Pericapsular Nerve Group (SPENG) block with combined posterior suprascapular and axillary nerve blocks in adults undergoi…
Sponsor: Izmir City Hospital • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Can a higher magnesium dose tame severe asthma attacks?
Disease control Not yet recruitingThe goal of this clinical is to compare treatment outcomes between high dose continuous IV Magnesium and standard therapy in the management of acute exacerbation of asthma in the emergency department. Participants will random assign to either high dose continuous IV drip or stand…
Sponsor: Thammasat University • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Implantable brain device aims to tame Drug-Resistant seizures
Disease control Not yet recruitingThe goal of this clinical trial is to demonstrate the safety and effectiveness of focal cortex stimulation with the EASEE(R) System in a large cohort of subjects with medically refractory focal epilepsy. The main questions it aims to answer are: 1. Is the percentage reduction of…
Sponsor: Precisis US, Inc. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Could a Gut-Focused drug revive immunotherapy for tough melanomas?
Disease control Not yet recruitingThis first-in-human study will evaluate the safety, clinical activity, and immunologic effects of combining axelopran with nivolumab in patients with PD-1-refractory unresectable or metastatic cutaneous melanoma. Exploratory analyses incorporating opioid exposure history and post…
Phase 1/2 • Sponsor: John Kirkwood • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Can we decode pancreatic cancer's resistance to chemotherapy?
Knowledge-focused Not yet recruitingAdvanced PDAC patients undergo polychemotherapy, yet responses are highly variable. Transcriptome signatures are emerging as key predictors of treatment response. However, PDAC adapts across sites (primary vs. metastases) and evolves under treatment pressure (pre- vs. post-chemot…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC